FindTrial
Sign In

Study on Compliance of Patients with Endocrine and Metabolic Diseases in the Population Cohort of 20220311

Study on Compliance of Patients with Endocrine and Metabolic Diseases in the Population Cohort of 20220311

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500095882
Enrollment
Unknown
Registered
2025-01-15
Start date
2025-01-15
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Geriatric diseases

Interventions

Control group:None
Observation group:None

Sponsors

Shenzhen People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients with simple lifestyle intervention or use of hypoglycemic drugs to control blood glucose. 2. With or without complications. 3. Patients aged 18-75 years old. 4. Informed consent, voluntary test.

Exclusion criteria

Exclusion criteria: 1. Those with incomplete information. 2. Patients with other types of diabetes. 3. Critically ill patients. 4. Patients with mental illness who cannot sign the informed consent form. 5. Those who refuse to participate in the survey. 6. Patients who cannot use artificial intelligence devices or cannot take care of themselves.

Design outcomes

Primary

MeasureTime frame
Patient sequence;—

Secondary

MeasureTime frame
Fasting and 2-hour postprandial (or OGTT 2-hour) blood glucose;Insulin;C-peptide;Glycated hemoglobin (HbA1c);Liver function;Renal function;Blood uric acid;Blood fat;Urinary albumin/creatinine ratio (UACR);Glomerular filtration rate (eGFR);—

Countries

China

Contacts

Public ContactKang Lin

Shenzhen People's Hospital

kang.lin@szhospital.com+86 180 2698 6527

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026